View this as a webpage
November 3, 2022
Novavax monovalent vaccine was recently authorized as a one-time booster dose for adults ages 18 years and older in limited situations. It is now available for ordering in MIIC. Please refer to the Oct. 21, COVID-19 Weekly Provider Update for additional details on the Novavax booster.
Moderna is currently evaluating lots of Moderna 10 and Moderna 5 vaccine for submission to the FDA for shelf-life extension. The first submission for extension is anticipated in the next few days. FDA will require time following submission to review these lots, so some vaccine may expire before this process is complete. Please quarantine and keep both Moderna 10 and Moderna 5 lots at correct storage temperature and conditions as they reach their expiration date to avoid possible administration errors with expired vaccine.
CDC is offering a series of brief webinars (15 to 20 minutes each) to educate immunization providers with the most up-to-date information on the COVID-19 vaccines, available at COVID-19 Vaccine Webinars. The new Recommendations for Bivalent COVID-19 Booster Doses course discusses recommendations for a bivalent COVID-19 booster dose, the interim COVID-19 immunization schedule, COVID-19 vaccine products, and recommended actions for addressing bivalent and monovalent COVID-19 vaccine administration errors.
Continuing education credit will be available through March 18, 2023.
|